Both in Diagnostics
Achieve Life Sciences vs Neogen
Over the past year ACHV returned +45.1% and NEOG returned +106.3%; their daily moves had a correlation of 0.12.
ACHV +45.1% NEOG +106.3%Growth of $1, one year, split-adjusted
| Metric | ACHV | NEOG |
|---|---|---|
| Price | $6.98 | $12.46 |
| Market cap | $719.7M | $2.72B |
| Today | +3.71% | +2.98% |
| 1 month | −0.7% | +4.2% |
| 6 months | +45.4% | +35.7% |
| Year to date | +40.4% | +78.3% |
| 1 year | +36.6% | +98.1% |
| Revenue growth (YoY) | — | +6.5% |
| Gross margin | — | 47.4% |
| Net margin | — | −5.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.1× |
| Net cash | $172.4M | -$605.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 42.2% |
| Short % of float | 28.1% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).